Donor CTLA-4 +49 A/G*GG genotype is associated with chronic GVHD after HLA-identical haematopoietic stem-cell transplantations

Blood

Volumn 110, Issue 13, 2007, Pages 4623-4624

  Azarian, Mariam ^b   Busson, Marc ^b   Lepage, Virginia ^b   Charron, Dominique ^b   Toubert, Antoine ^b   Loiseau, Pascale ^a   De Latour, Regis Peffault ^b   Rocha, Vanderson ^b   Socié, Gerard ^b  

^a SAINT LOUIS HOSPITAL   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; CYTOTOXIC T-LYMPHOCYTE ANTIGEN 4; DIFFERENTIATION ANTIGEN; HLA ANTIGEN; LEUKOCYTE ANTIGEN; UNCLASSIFIED DRUG;

ACUTE GRAFT VERSUS HOST DISEASE; BLOOD GROUP ABO INCOMPATIBILITY; CANCER RELAPSE; CANCER SURVIVAL; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CHRONIC GRAFT VERSUS HOST DISEASE; CTLA 4 GENE; GENE; GENE LINKAGE DISEQUILIBRIUM; GENETIC POLYMORPHISM; GENOTYPE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA TYPING; HUMAN; IMMUNE RESPONSE; LETTER; PRIORITY JOURNAL; RISK FACTOR; T LYMPHOCYTE ACTIVATION; CHRONIC DISEASE; DONOR; GENETICS; GRAFT VERSUS HOST REACTION; ISOGRAFT;

ANTIGENS, CD; ANTIGENS, DIFFERENTIATION; CHRONIC DISEASE; GENOTYPE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA ANTIGENS; HUMANS; POLYMORPHISM, GENETIC; TISSUE DONORS; TRANSPLANTATION, ISOGENEIC;

EID: 39649093684     PISSN: 00064971     EISSN: 00064971     Source Type: Journal    
DOI: 10.1182/blood-2007-08-106385     Document Type: Letter

References (7)

1. Ueda H, Howson JMM, Esposito L, et al. Association of the T-cell regulatory gene CTLA-4 with susceptibility to autoimmune disease. Nature. 2003;423:506-511.
2. Kristiansen OP, Larsen ZM, Pociot F. CTLA-4 in autoimmune diseases- a general susceptibility gene to autoimmunity. Genes Immun. 2000;1:170-184.
3. Pérez-García A, De la Camara R, Roman-Gomez J, et al. CTLA-4 polymorphisms and clinical outcome after allogeneic stem cell transplantation from HLA-identical sibling donors. Blood. 2007;110:461-467.
4. Kouki T, Sawai Y, Gardine CA, et al. CTLA-4 Gene Polymorphism at position 49 in Exon 1 Reduces the Inhibitory Function of CTLA-4 and Contributes to the Pathogenesis of Graves' Disease. J Immunol. 2000;165:6606-6611.
5. Anjos S, Nguyen A, Ounissi-Benhalkar H, et al. A common autoimmunity predisposing signal peptide variant of the cytotoxic T-lymphocyte antigen 4 results in inefficient glycosylation of the susceptibility allele. J Biol Chem. 2002;277:46478-46486.
6. Ligers A, Teleshova N, Masterman T, et al. CTLA-4 gene expression is influenced by promoter and exon 1 polymorphism. Genes Immun. 2001;2:145-152.
7. Dickinson AM, Charron D. Non-HLA immunogenetics in hematopoietic stem cell transplantation. Curr Opin Immunol. 2005;17:517-525.